PHOTO
Dubai, UAE: Doctors at the American Hospital Dubai have announced the success of a highly complex bronchial artery embolization procedure for a patient who presented with moderate haemoptysis, and suffering from cavitation mycobacterium tuberculosis of approximately ten cms
Dr. Aws Al Fahad, Consultant interventional radiologist at the American hospital Dubai, commented: “This was an extremely complex procedure and a first in the UAE according to senior physicians including our chief of pulmonology and critical care (Dr Mazin Zouwayhed). Despite the best medical management, the patient continued to have moderate haemoptysis. We recommended the bronchial artery embolization procedure, and fortunately, the haemoptysis was resolved successfully. We are pleased the patient is making good progress and recovering well in our isolation unit. At American hospital Dubai, we continue to introduce new technologies that support the community.”
The procedure involved running a catheter through the leg of the patient into an artery that supplies blood to the bronchi. Next was the application of dye into the artery to identify the abnormal hypertrophic bronchial arterioles (often the source of the bleeding). This was done in angio room using image subtracted technology. Once we ascertained of our position with these diseased bronchial arteries, tiny particles were injected to clot the vessel, close the bleeding, and abnormal bronchial vascular.
The lung perfusion was spared as this was provided by the pulmonary arteries which were not impacted in this procedure.
The patient, Mr Mohammad Sikdar, said” I had a good experience in the American hospital Dubai, the medical team played a major role to treat me well. I feel much better now, soon, I will pursue my life normally”
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
